Michael Stapleton resigned as COO of Accelrys, effective the end of 2002. Joseph Mollica will serve as acting COO until a replacement is named.
Kevin Sanborn moved up in the ranks at Millipore. Formerly VP of strategic planning and business development, he’s now president of the company’s life sciences division.
Deltagen recently created an office of the chairman, and Constantine Anagnostopoulos, a retired exec from Monsanto, will be the first chairman of the board.
David Evjen is the new CEO of Technologene, a San Jose, Calif.-based company in proteomics. Evjen comes from Med-Cor.
NuGen Technologies welcomed aboard James Stanchfield, its new VP of commercial operations. Stanchfield comes to the San Carlos, Calif., company from Arcturus Engineering.
Baylor genome scientist Michael Metzker got kudos recently for his genetic analysis work using HIV sequence data on a case in which a physician is charged with attempting to murder his girlfriend by infecting her with HIV.
Chris Ashton became CEO of the UK’s new knockout mouse company, Etiologics, after leaving his VP post at Orchid BioSciences.
NHGRI has done some staff shuffling in the last couple of months. Among the new titles: Eric Green, scientific director and director of NHGRI’s intramural research; William Gahl, intramural clinical director; Mark Guyer, director of extramural research; and Jane Peterson and Bettie Graham, both associate directors for extramural research. New faces at NHGRI in the office of the director include Christopher Austin and Jean Jenkins.
Structural Bioinformatics hired Hanne Dannulat, formerly at GlaxoSmithKline, as European managing director.
Bill Crosby, last seen at the National Research Council, headed to the University of Saskatchewan, where he is the director of bioinformatics.
Pennsylvania’s state government lost Fritz Bittenbender, secretary of administration, as he moves on to be president of the Pennsylvania Biotechnology Association, which will help the state distribute its $2 billion earmarked for life sciences growth.
Gijs van Rooijen joins Genome Prairie, a Calgary-based firm helping genomics take hold in Canada, as its first chief scientific officer. Van Rooijen was previously at SemBioSys Genetics, heading up the cellular and molecular biology division, and held a faculty position at the University of Calgary.